Rezultati pretrage - Waylan Bessler

  • Prikaz rezultata 1 – 8 od 8
Detaljiziraj rezultate
  1. 1
    Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood

    Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood od Munaza Javed, Laura E. Mead, Daniel N. Prater, Waylan Bessler, David Foster, Jamie Case, W. Scott Goebel, Mervin C. Yöder, Laura S. Haneline, David A. Ingram

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans

    Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans od Elisabeth A. Lasater, Fang Li, Waylan Bessler, Myka L. Estes, Sasidhar Vemula, Cynthia M. Hingtgen, Mary C. Dinauer, Reuben Kapur, Simon J. Conway, David A. Ingram

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors

    Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors od Jamie Case, Laura E. Mead, Waylan Bessler, Daniel N. Prater, Hilary White, M. Reza Saadatzadeh, Janak R. Bhavsar, Mervin C. Yöder, Laura S. Haneline, David A. Ingram

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/− mast cells

    Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/− mast cells od Andrew S. McDaniel, Jayme D. Allen, Su-Jung Park, Zahara M. Jaffer, Elizabeth G. Michels, Sarah J. Burgin, Shi Chen, Waylan Bessler, Clemens Hofmann, David A. Ingram, Jonathan Chernoff, D. Wade Clapp

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation

    Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation od Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Jiang Li, Qingbo Lu, Julie A. Mund, Xiaohong Li, Waylan Bessler, Shaomin Qian, William E. Dyer, George E. Sandusky, Andrew Horvai, Amy E. Armstrong, D. Wade Clapp

    Izdano 2019
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics

    p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics od Jayme D. Allen, Zahara M. Jaffer, Su-Jung Park, Sarah J. Burgin, Clemens Hofmann, Mary Ann Sells, Shi Chen, Ethel Derr‐Yellin, Elizabeth G. Michels, Andrew S. McDaniel, Waylan Bessler, David A. Ingram, Simon J. Atkinson, Jeffrey B. Travers, Jonathan Chernoff, D. Wade Clapp

    Izdano 2009
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

    Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial od Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp

    Izdano 2021
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK

    Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK od Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, Marc Ferrer, Steven P. Angus, Eric Hawley, Alejandra M. Petrilli, Roberta L. Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan Bessler, Xiaohu Zhang, Rajarshi Guha, Craig J. Thomas, Sarah S. Burns, Thomas S.K. Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A.H. Dixon, Andrea R. Masters, David R. Jones, Charles W. Yates, Stephen J. Haggarty, Salvatore La Rosa, D. Bradley Welling, Anat Stemmer‐Rachamimov, Scott R. Plotkin, James F. Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernández‐Valle, Gary L. Johnson, Jaishri O. Blakeley, D. Wade Clapp

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: